Drug shortages
HHS proposes policies to prevent drug shortages. Find out how AHA is collaborating with the private sector to mitigate supply chain vulnerabilities.
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America鈥檚 Pharmaceutical Supply Act, legislation that would require the Department of Health and Human Services to update its essential medicines list and create a database to help predict鈥
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its support for multiple bills in the Senate to address drug shortages and shore up the nation鈥檚 fragile pharmaceutical supply chain.
The 黑料正能量 Association submits comments to the Senate Committee on Finance regarding the important topic of drug shortages.
The House Energy and Commerce Committee held a hearing on legislative proposals to prevent and respond to generic drug shortages.
AHA's comments on Energy and Commerce Committee Chair Rodgers鈥 drug shortages discussion draft.
AHA recently voiced support for four bipartisan bills introduced in the Senate to help alleviate the nation鈥檚 chronic and growing drug shortages.
The Drug Shortage Prevention Act would require manufacturers to notify the Food and Drug Administration (FDA) of increased demand of covered drugs. The AHA believes the requirement that manufacturers notify the FDA of increased demand for critical drugs will be an integral tool for shoring up the鈥
Pfizer will ship certain sterile injectable products directly to customers due to high demand after a tornado struck the plant that makes them.
The Food and Drug Administration said it did not expect 鈥渁ny immediate significant impacts on supply鈥 after a tornado damaged a Pfizer plant in North Carolina that makes sterile injectables for U.S. hospitals, but is working with Pfizer to complete a more extensive assessment and will share more鈥
The Senate Health, Education, Labor and Pensions Committee voted 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029.